Moistus Eye Drops
Polyethylene Glycol 0.4% + Propylene Glycol 0.3% — Artificial Tears
| Composition | Polyethylene Glycol 0.4% + Propylene Glycol 0.3% w/v |
|---|---|
| Dosage Form | Eye Drops |
| Pack Type | Bottle |
| Pack Size | 10ml |
| MRP | ₹ 180 |
| Therapy | Ophthalmic — Artificial tears (polyethylene glycol-based) |
| Storage | Store below 25°C. |
📱 WhatsApp Enquiry📞 Call: +919041677932
About Moistus Eye Drops
Moistus Eye Drops contains Polyethylene Glycol 0.4% w/v + Propylene Glycol 0.3% w/v — modern long-residence-time artificial tears for dry eye syndrome.
Indicated for symptomatic relief of dry eye syndrome, computer vision syndrome, environmental dryness (AC exposure, contact lens wear) and meibomian gland dysfunction.
Camrut Healthcare manufactures Moistus Eye Drops under WHO-GMP injectable conditions for PCD pharma franchise across India.
Indications
- Dry eye syndrome (mild-to-moderate)
- Computer vision syndrome
- Contact lens-related dryness
- Post-LASIK dryness
- Meibomian gland dysfunction (adjunctive)
Mechanism of Action
Polyethylene Glycol and Propylene Glycol are hydrophilic polymers that bind water molecules, providing extended-residence-time tear-film lubrication. The viscous solution coats the corneal surface and reduces evaporation.
Dosage & Administration
['Instill 1–2 drops in affected eye 4–6 times daily', 'Use as often as needed', 'Wait 5 minutes between different eye drops']
Side Effects
['Transient blurred vision after instillation', 'Mild stinging occasionally']
Contraindications & Precautions
['Hypersensitivity to PEG or propylene glycol', 'Active eye infection (consult doctor)']
Storage
Store below 25°C.
Moistus Eye Drops is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
q
a
q
a
q
a
q
a
q
a
Related Products